Alert the Pharmacist if Patients on Gliptins Complain of Shortness of Breath
June 2016
You'll hear more about the cons of using "gliptins" (Januvia, Onglyza, etc) for diabetes.
That's because some gliptins have been under fire for concerns about an increased risk of heart failure in certain patients.
Plus these meds don't improve blood sugar that much...and don't help patients lose weight.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote